Azis Dabas, healthcare AI growth operator

Azis Dabas / Healthcare operating systems

I build the operating systems behind healthcare growth.

Payer strategy, provider growth, pharmacy, claims intelligence, and governed AI delivery, connected through accountable execution.

Direct operating record

Built inside regulated healthcare.

Operating experience from the current executive resume. Organization references do not imply endorsement.

01

Mindful Care

Director, Business Development & Marketing / 2025

02

Doral Health & Wellness

Business Account Manager / Business Development & Growth / 2025

03

Atlantic Dialysis Management Services

Field Marketing Manager / Business Development / 2024-2025

04

Nova Q Health / Viva Pharmacy

Pharmacy Director / Business-Building & Operating Leadership / 2019-2023

The executive view

Evidence reviewed

Healthcare's next advantage is how the parts work together.

My operating thesis: growth holds when patient access, payer economics, team capacity, and technology delivery are designed together. Improving one function can simply move the burden to another.

01From AI adoption to operating change

McKinsey identifies integration and workforce redesign as scaling challenges. Rock Health emphasizes domain expertise and measurable outcomes as AI becomes more widely available.

Operating decision

Choose the journey to improve before choosing the technology. Name its owner and the value that must survive implementation.

02From connected records to completed care

TEFCA supports information exchange across organizations. CMS's April 2026 proposal would extend electronic prior authorization requirements to drugs; it is not a final rule.

Operating decision

Connect coverage, referral, scheduling, pharmacy, and follow-up. Data availability alone does not assign responsibility for the next handoff.

03From a human checkpoint to real authority

A July npj Digital Medicine letter argues that oversight needs understanding, time, decision rights, and effective intervention. FDA's August discussion paper asks how generative AI devices should be evaluated and monitored.

Operating decision

Define who can stop or override an action, what evidence they need, and when the system must be reevaluated. A launch is the start of accountability.

My role is to connect the commercial strategy, operating design, and implementation plan. Clinical, coverage, and regulatory decisions stay with the accountable professionals.

Read the full operating thesis

The healthcare operating world

Who owns
the next handoff?

A referral becomes care only when coverage, capacity, clinical decisions, therapy access, and payment align. This illustrative therapy-access journey makes the dependencies visible, including where work must stop for an accountable decision.

Whole-system architecture
Detailed healthcare architecture connecting a hospital, pharmacy, diagnostic laboratory, payers, data infrastructure, public policy, and governance around one patient episode.
05 connected domainsNeed to outcome to next need

Selected area / 06

Pharmacy + therapy

Pharma, biotech, devices, labs, imaging, PBMs, pharmacies, formularies, medication access, and adherence.

Operating responsibility

Connect the prescription, benefit requirements, prescriber information, affordability, inventory, pharmacist review, and patient follow-through.

The executive operating sequence

From signal to a decision that holds.

01 Market Signal

What changed, where, and why now?

Policy, epidemiology, utilization, clinical evidence, technology, capacity, and buyer behavior are separated from noise so leadership can name the system event and its second-order effects.

Decision
Leadership signal
Read the market briefs

02 Payer Economics

Where does value become contractable?

CMS, state, employer, payer, PBM, and provider incentives are translated into the reimbursable unit, total cost, risk transfer, purchasing authority, and conditions for a commercial test.

Decision
Commercial thesis
Explore payer and provider work

03 Provider Field

Can provider motion launch inside the real field?

Primary, specialty, behavioral, post-acute, home, virtual, and pharmacy capacity are connected through referral, access, navigation, workflow fit, and accountable handoffs.

Decision
Launchable network motion
View network-growth evidence

04 Claims / RCM Intelligence

Where do claims reveal the commercial wedge?

Medical and pharmacy claims, eligibility, coding, prior authorization, denials, leakage, and payment integrity expose where intervention can improve access, cash, and trust.

Decision
Commercial wedge
View claims-intelligence work

05 AI Execution

Where should AI act, stop, and escalate?

Rules, models, agents, applications, workflow, marketing, and RevOps actions are bounded by source context, risk tier, human authority, reversible controls, and accountable owners.

Decision
Governed execution
Explore healthcare AI execution

06 Governance / Proof

What evidence survives scrutiny and enables a decision?

Safety, quality, access, equity, drift, audit trails, operating burden, and finance-validated value resolve into an evidence threshold, accountable owner, and next allocation decision.

Decision
Decision confidence
Assess commercial readiness

Verified proof

Evidence with a visible boundary.

Qualitative records are presented by relationship type. Organization names do not imply endorsement.

01 / Approved case

Founder-to-Exit Specialty Pharmacy

Approved qualitative case record for a founder-to-exit regulated healthcare operating build.

Operating stateReady
Open the record
02 / Confirmed role

Claims Forensics and Referral Leakage

Direct business-development operating role spanning provider-network growth, claims intelligence, payer strategy, service-line commercialization, and M&A diligence.

Operating stateReady
Open the record
03 / Confirmed role

Dialysis Network Growth

Direct business-development operating role in dialysis referral architecture, intake redesign, facility growth, and payer-aligned field execution.

Operating stateReady
Open the record

System architecture / the whole health economy

One care journey. Four kinds of accountability.

A faster task is not enough. The patient must move forward, the economics must work, the information must be usable, and someone must own the decision. This is the whole-system test I apply to growth and transformation.

A

Person and episode

Need to outcome to next need

Identity, consent, coverage, navigation, care, therapy, recovery, and follow-through remain one longitudinal thread even when organizations and settings change.

B

Value and risk

Financing to contract to reinvestment

Premiums, public funding, benefits, contracts, reimbursement, product spend, operating burden, and capital allocation determine what the system can sustain.

C

Context and evidence

Source to action to learning

Clinical, pharmacy, claims, operational, and patient-generated data must carry provenance, purpose, freshness, and outcome evidence across every handoff.

D

Authority and accountability

Policy to permission to intervention

Regulators, sponsors, payers, clinicians, pharmacists, operators, patients, and AI systems need explicit decision rights, thresholds, escalation, and auditability.

Where handoffs fail

Critical interface

What must transfer

What can go wrong

01

Coverage Access

Eligibility, attribution, benefit, and authorization

A covered service is not necessarily an available service.

02

Access Care

Navigation, referral, scheduling, capacity, and trust

Demand, geography, network status, and workflow rarely align on their own.

03

Care Therapy

Diagnosis, order, formulary, dispensing, monitoring, and adherence

Clinical intent can fail at affordability, supply, authorization, or follow-through.

04

Care + therapy Transaction

Documentation, coding, claim, remittance, and reconciliation

Delivered value and reimbursable evidence are different operating objects.

05

Transaction Evidence

Utilization, outcomes, cost, burden, quality, and equity

Activity can be measured precisely while value remains unresolved.

06

Evidence Financing + capacity

Contracting, procurement, investment, network, and workforce decisions

Evidence only matters when it changes an allocation or operating decision.

07

Next decision Need

Learning, prevention, outreach, benefit change, and system redesign

A health system is not closed until evidence changes what happens next.

The full architecture: 10 domains, 5 controls

The invariant / one person and episode

Next decision returns to need
  1. 01Need
  2. 02Coverage
  3. 03Access
  4. 04Care
  5. 05Therapy
  6. 06Transaction
  7. 07Evidence
  8. 08Financing
  9. 09Capacity
  10. 10Next decision

Where10 health-system domainsThe terrain in which care, risk, data, and value exist.

How5 control planesThe rules by which context becomes governed action.

Travel6 decision chaptersThe operating path from a signal to a leadership decision.

01

People and populations

Patients, members, caregivers, communities, public health, and the social conditions that shape need and access.

From isolated encounters to longitudinal health trajectories with consent, continuity, and accountable follow-through.

02

Coverage, benefit, and risk

Medicare, Medicaid, commercial plans, employers, states, value-based contracts, benefit design, and risk allocation.

From paying for activity to making affordability, access, outcomes, and total cost visible in the same operating model.

03

Access and network

Eligibility, attribution, directories, navigation, referral, scheduling, authorization, and provider capacity.

From fragmented entry points to demand-and-capacity orchestration across settings, service lines, and populations.

04

Care delivery

Primary, specialty, acute, behavioral, post-acute, home, virtual, community, and longitudinal care teams.

From episodic handoffs to coordinated pathways with explicit ownership, exceptions, and escalation.

05

Pharmacy, therapeutics, and diagnostics

Pharma, biotech, devices, labs, imaging, PBMs, pharmacies, formularies, medication access, and adherence.

From a parallel product channel to an integrated medical-pharmacy-therapy loop tied to evidence and patient outcomes.

06

Transactions and revenue

Coding, claims, prior authorization, remittance, denials, RCM, payment integrity, and program integrity.

From retrospective repair to pre-service intelligence, cleaner transactions, and shared exception resolution.

07

Data, identity, and interoperability

EHRs, HIEs, FHIR APIs, TEFCA exchange, patient identity, consent, devices, real-world data, and provenance.

From copied records to a governed context fabric that carries source, freshness, purpose, and permissions with the data.

08

Intelligence and orchestration

Rules, analytics, models, agents, applications, workflow automation, marketing, RevOps, and operational control planes.

From passive dashboards and copilots to bounded action that can route work, use tools, stop, and escalate.

09

Governance and human authority

Clinical safety, privacy, security, compliance, quality, equity, decision rights, auditability, and accountability.

From a human-in-the-loop label to designed authority: time to judge, power to intervene, and reversible controls.

10

Evidence, learning, and capital

Outcomes, real-world performance, evaluation, drift, health economics, procurement, investment, and value realization.

From launch metrics to a learning system that reconciles patient impact, operating burden, financial value, and the next allocation decision.

The healthcare AI control plane

The architecture I would design for is not one autonomous model running healthcare. It gives specialized tools the right context, limits their actions, preserves human authority, and measures what changes in care and economics. This is a design position, not a forecast of universal adoption.

  1. 01Context

    Assemble identity, consent, clinical state, economic state, workflow position, and provenance for the decision at hand.

  2. 02Policy

    Translate regulation, benefits, contracts, clinical guidance, and organizational rules into executable boundaries.

  3. 03Action

    Route tasks, transactions, therapy access, communications, product behavior, and operating work across the system.

  4. 04Authority

    Name who may decide, what AI may do, when work must stop, and who owns exceptions, overrides, and escalation.

  5. 05Evaluation

    Measure safety, outcomes, access, equity, burden, drift, economics, and whether the system should expand, change, or stop.

Read the architecture brief

This is the diagnostic model for the whole health system. The verified proof on this page distinguishes direct operating experience from system-wide analysis.

Authority stream

A point of view that stays close to the work.

Operator story

Boardroom strategy. Field-level execution.

Azis R. Dabas works where healthcare strategy meets the operating detail: reimbursement, provider access, claims, product delivery, and the governance required to put a system into use.

Read the operator story

Start a serious conversation

Bring the market signal. Leave with an operating decision.

Discuss an operating mandate